Subscribe To
Ascendis Pharma Opens Compassionate Use Program for TransCon™ PTH (palopegteriparatide) in Germany
– Compassionate use enables treating physicians in Germany to request access to investigational TransCon PTH (palopegteriparatide) for eligible adult patients with hypoparathyroidism COPENHAGEN, Denmark, June 05, 2023 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced that it has started enrollment for a Compassionate Use Program (CUP) in Germany for TransCon PTH (palopegteriparatide), an […] The post Ascendis Pharma Opens Compassionate Use Program for TransCon™ PTH (palopegte...
Read More
Content Topics
Ascendis
Pharma
Opens
Compassionate
Program
Transcon
Transcon
palopegteriparatide
Germany
Forex
Posted: Jun 5 2023, 21:30
Author Name: forextv
Views: 102163